
- Home
- Press Releases
- Cannabis Testing Market to Reach USD 2,669.45 Million by 2028
Cannabis Testing Market to Reach USD 2,669.45 Million by 2028
The Cannabis Testing Market is expected to reach USD 2,669.45 million by 2028, growing at a CAGR of 12.72% between 2021 to 2028. The growing cannabis cultivators for examining and quality management of hemp yields will drive the industry growth of cannabis testing laboratories in the future years. Different institutions deliver accreditation to laboratories that conduct analytical testing of hemp and cannabis-derived goods. As testing of cannabis effects is required for confirming the safety and efficacy of the product, the need for cannabis testing will determine the number of laboratories delivering cannabis testing assistance.
Key Findings:
- The services segment is projected to expand at the fastest CAGR exceeding 11% over the forecast period owing to the increased legalization of cannabis and the subsequent increase in the demand for cannabis testing.
- The laboratories segment held a market share of around 34% in 2020. This share is due to the rising strong government support for the legalization of medical marijuana.
- Asia Pacific is expected to expand at a CAGR over 10.5% from 2021 to 2028. This surge is attributed to the rising demand for Cannabis Testing in developing economies such as China and India.
Some of the key players in cannabis testing market are include Agilent Technologies, Inc., Shimadzu Corporation, MERCK KGAA, Thermo Fisher Scientific, DigiPath, Inc., Steep Hill Inc., SC Laboratories, Inc., and PharmLabs LLC. among others. The market is comprised of a high degree of competition due to the presence of numerous key players.
Medical cannabis has been established useful in different medical applications, such as relieving nausea driven due to chemotherapy, promoting appetite in AIDS patients, maintaining muscular spasms in numerous sclerosis patients, and lowering intraocular pressure in patients with glaucoma. Having health benefits, management in different nations are legalizing the usage of medical cannabis. As medical cannabis is being legalized in many states globally, the need for the analytical testing of cannabis for securing its safety before human consumption has grown in recent years.
North America is expected to record the highest CAGR, owing to the increasing demand in countries, such as the U.S., Canada, and Mexico. The rising number of testing laboratories and growing cultivators of cannabis will boost the industry demand. Furthermore, advancing R&D activities pertaining to the commercialization of cannabis by-products is assured to increase the market revenue during the predicted timeline.
The Cannabis Testing is segmented as follows:
-
Global Cannabis Testing Market: Type Segment Analysis
- Products
- Services
- Software
-
Global Cannabis Testing Market: Application Segment Analysis
- Laboratories
- Cannabis Drug Manufacturers and Dispensaries
- Other End Users
-
Global Cannabis Testing Market: Segment Analysis
-
Global Cannabis Testing Market: Segment Analysis
- Agriculture
Browse market data Tables and Figures
spread through
Pages and in-depth TOC on "Cannabis Testing Market by Type (Products, Services, Software), by Application (Laboratories, Cannabis Drug Manufacturers and Dispensaries, Other End Users), by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)"
View detailed Research Report here - https://www.vantagemarketresearch.com/industry-report/cannabis-testing-market-1097
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
About us
Vantage Market Research is a reputed company committed to providing high quality data and market research services. The company provides quantified B2B high quality research on more than 20,000 emerging markets. The company offers detailed reports on multiple industries including chemical materials and energy, food and beverages, healthcare, technology, etc. The company comprises over 125 analysts and consultants, adding more than 1,100 market research reports to its vast database every year. The company’s clientele base spans across 70% of the Global Fortune 500 companies.
Contact us
Vantage Market Research
6218 Georgia Avenue NW Ste 1 - 564 Washington
DC 20011-5125 United States
Tel: +1 202 380 9727
Email:
[email protected]